Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer. - Feliu, J.; Borrega, P.; León, A.; López-Gómez, L.; López, M.; Castro, J.; Belda-Iniesta, C.; Barriuso, J.; Martínez, V.; González-Barón, M. (Cancer Chemotherapy & Pharmacology, 2011)